<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">38917451</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-7385</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Jun</Month><Day>24</Day></PubDate></JournalIssue><Title>American journal of physical medicine &amp; rehabilitation</Title><ISOAbbreviation>Am J Phys Med Rehabil</ISOAbbreviation></Journal><ArticleTitle>Effects of Cardiopulmonary Rehabilitation on Cardiorespiratory Fitness and Clinical Symptom Burden in Long COVID: Results from the COVID-Rehab Randomized Controlled Trial.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1097/PHM.0000000000002559</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the effectiveness of an eight-week cardiopulmonary rehabilitation program on cardiorespiratory fitness (VO2peak) and key cardiopulmonary exercise test measures, quality of life, and symptom burden in individuals with Long COVID.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Forty individuals with Long COVID (mean age 53 &#xb1; 11 years), were randomized into 2 groups: 1/ Rehabilitation group: centre-based individualized clinical rehabilitation program (8 weeks, 3 sessions per week of aerobic and resistance exercises, and daily inspiratory muscle training) and 2/ Control group: individuals maintained their daily habits during an eight-week period.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was a significant difference between groups in mean VO2peak improvement (p = 0.003). VO2peak improved significantly in the rehab group (+2.7 mL.kg.min 95%IC:+1.6 to +3.8 p &lt; 0.001) compared to the control group (+0.3 mL.kg.min 95%IC:-0.8 to +1.3 p = 0.596), along withVE/VCO2 slope (p = 0.032) (-2.4 95%IC:-4.8 to +0.01 p = 0.049 and + 1.3 95%IC:-1.0 to +3.6 p = 0.272 respectively) and VO2 at first ventilatory threshold (p = 0.045). Furthermore, all symptom impact scales improved significantly in the rehabilitation group compared to the control group (p &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">An individualized and supervised cardiopulmonary rehabilitation program was effective in improving cardiorespiratory fitness, ventilatory efficiency, and symptom burden in individuals with Long COVID. Careful monitoring of symptoms is important to appropriately tailor and adjust rehabilitation sessions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Besnier</LastName><ForeName>Florent</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Malo</LastName><ForeName>Jacques</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Mohammadi</LastName><ForeName>H&#xe2;nieh</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Clavet</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Klai</LastName><ForeName>Chiheb</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Research center and Centre &#xc9;PIC, Montreal Heart Institute, Montr&#xe9;al H1T 1N6, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Research center and Centre &#xc9;PIC, Montreal Heart Institute, Montr&#xe9;al H1T 1N6, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xe9;rub&#xe9;</LastName><ForeName>B&#xe9;atrice</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Lecchino</LastName><ForeName>Catia</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Iglesies-Grau</LastName><ForeName>Josep</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Vincent</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Research center and Centre &#xc9;PIC, Montreal Heart Institute, Montr&#xe9;al H1T 1N6, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagnon</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Research center and Centre &#xc9;PIC, Montreal Heart Institute, Montr&#xe9;al H1T 1N6, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaudreau-Majeau</LastName><ForeName>Flavie</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Psychology, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al H3C 3J7, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juneau</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Simard</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>L'Allier</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Nigam</LastName><ForeName>Anil</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Gayda</LastName><ForeName>Mathieu</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Bherer</LastName><ForeName>Louis</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Phys Med Rehabil</MedlineTA><NlmUniqueID>8803677</NlmUniqueID><ISSNLinking>0894-9115</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CoiStatement>Conflicts of Interest: The authors have no actual or potential conflicts of interest related to this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>25</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>25</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>25</Day><Hour>16</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38917451</ArticleId><ArticleId IdType="doi">10.1097/PHM.0000000000002559</ArticleId><ArticleId IdType="pii">00002060-990000000-00526</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>